BioPharma Dive » Clinical Trials
5 FOLLOWERS
This section of the BioPharma Dive library features a distinct collection of articles sharing ideas and perceptive, medical acumen on the topic of Clinical Trials. A leading Clinical publication and website, BioPharma Dive provides in-depth journalism and insight into the most impactful news and trends shaping biotech and pharma.
BioPharma Dive » Clinical Trials
1w ago
The results have led Amylyx to pause promotion of Relyvrio and potentially pull it from the market in the coming weeks, a major blow to the company and ALS patients ..read more
BioPharma Dive » Clinical Trials
1w ago
Justin Klee and Joshua Cohen spoke to BioPharma Dive about the next steps for their company, which is considering pulling its only product from market after the drug failed a confirmatory study in ALS ..read more
BioPharma Dive » Clinical Trials
1w ago
Roche said its experimental Alzheimer’s disease drug trontinemab showed it might be able to clear brain plaques faster than other medicines ..read more
BioPharma Dive » Clinical Trials
1w ago
The setback shuts out Acadia’s top medicine from a large sales opportunity and heightens the biotech’s dependence on a pipeline filled with risky drug prospects.  ..read more
BioPharma Dive » Clinical Trials
1w ago
The pharma intends to test a single-dose regimen as well as a shot that may provide broader protection than the current versions of Gardasil that regularly generate billions in annual sales ..read more
BioPharma Dive » Clinical Trials
3w ago
The agency’s complete response letter knocks back Minerva’s attempt to secure approval of the drug over agency reviewers’ objections ..read more
BioPharma Dive » Clinical Trials
3w ago
The biotech’s drug led to significant weight loss in a Phase 2 trial, causing shares to double as analysts compared results to the marks set by drugs from Eli Lilly and Novo Nordisk ..read more
BioPharma Dive » Clinical Trials
3w ago
Analysts viewed results for one of Janux’s drug, a T cell engager aimed at metastatic prostate cancer, as potentially best-in-class in a field that’s crowded with competitors ..read more
BioPharma Dive » Clinical Trials
3w ago
How are knowledge graphs changing the path of drug discovery ..read more
BioPharma Dive » Clinical Trials
3w ago
The updated results show that responses to the drug, which is currently in late-stage testing, deepened with time, helping the company rebound from an earlier setback ..read more